FDA Approved: ILEVRO — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved ILEVRO (nepafenac) from Novartis Pharmaceuticals Corporation as the original application for reducing postoperative pain and inflammation following…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Inflammation
• Postoperative Pain

Drugs mentioned

• ILEVRO (nepafenac)

Snippet

ORIG AP for ILEVRO (NEPAFENAC)